Kindwise
Latest round
- Series B
Last raised
- Dec 2024
Total raised
- $28M
Investors
- 4
About Kindwise
Based in Wuhan, China, and founded in 2018, Kindwise operates as a biological diagnosis and treatment service provider, focusing on the innovative products for diagnosis and treatment of gynaecological tumours. It is a National High-Tech Enterprise. The chairman of the board, Ding Ma, is an academician of the Chinese Academy of Engineering. It has cooperated with Wuhan Central Hospital, Guangdong Provincial Women and Children's Health Hospital, Shenzhen Second People's Hospital and the Third Affiliated Hospital of Zhengzhou University and other hospitals. Kindwise specializes in innovative diagnostic solutions and therapeutic products for gynaecological oncology. Their core offerings include technologies for HPV detection and typing, as well as early diagnostic kits for breast cancer and cervical cancer treatments. The company's flagship products, such as the HPV typing and integrated detection kits, aim to enhance precision in diagnosis and improve patient outcomes by facilitating early intervention. The integration of high-throughput sequencing technologies, such as those from ILLUMINA, further strengthens their product line-up by enabling comprehensive genomic analysis. The company generates revenue by providing biological diagnosis and treatment services.
Who invested in Kindwise
4 investors across 1 round
See all investors in Kindwise
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 5, 2024
Amount
$28M
Investors
Questions about Kindwise
Who invested in Kindwise?
Kindwise has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kindwise raised?
Kindwise has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kindwise last raise money?
Kindwise's most recent round on record is a Series B, in Dec 2024.
What does Kindwise do?
Based in Wuhan, China, and founded in 2018, Kindwise operates as a biological diagnosis and treatment service provider, focusing on the innovative products for diagnosis and treatment of gynaecological tumours.
Where is Kindwise headquartered?
Kindwise is headquartered in Wuhan, China.
Which VCs invest in companies like Kindwise?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Kindwise's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Kindwise? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.